SCHEMBL184119

SCHEMBL184119

Cc1cc(C(=O)Nc2ccc(-c3ccc(C4CC[CH]CC4)cc3)nc2)c(C)[nH]1

nearest known ligand 0.45

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 5/20 0.41
PTPN2 P17706 2/20 0.41
DGAT1 O75907 5/20 0.41
PTPN6 P29350 1/20 0.40
PTPN11 Q06124 1/20 0.40
MCHR1 Q99705 5/20 0.38
PPARG P37231 1/20 0.37
FASN P49327 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL180987 0.86 DGAT1 (0.58) DGAT1
SCHEMBL180779 0.67 DGAT1 (0.58) DGAT1
SCHEMBL180680 0.66 DGAT1 (0.56) DGAT1
SCHEMBL1448295 0.66 HTR2C (0.51) DGAT1MCHR1FASN
SCHEMBL180995 0.65 DGAT1 (0.61) PTPN1PTPN2DGAT1MCHR1
SCHEMBL180840 0.65 DGAT1 (0.53) DGAT1
SCHEMBL180755 0.65 DGAT1 (0.49) PTPN1PTPN2DGAT1MCHR1
SCHEMBL180908 0.65 DGAT1 (0.57) DGAT1
SCHEMBL180846 0.65 DGAT1 (0.60) DGAT1
SCHEMBL180618 0.65 DGAT1 (0.67) DGAT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2402317-A1 DGAT inhibitor Novartis AG (CH) 2012-01-04 EP disclosed